Biotech News

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Medpace (MEDP)Medpace2026-06-25 13:46 ESTEarnings

Revenue of $659.9 million in the third quarter of 2025 increased 23.7% from revenue of $533.3 million for the comparable prior-year period, representing a backlog conversion rate of 23.0%. Net new business awards were $789.6 million in the third quarter of 2025, representing an increase of 47.9%

Open original release

Related news

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. Reports First Quarter 2025 Results

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026

MEDPMedpace2026-06-25 13:46 EST

Medpace Holdings, Inc. Reports First Quarter 2026 Results

View all latest news

Medpace

Medpace is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MEDPMedpace2026-06-26 15:30 EST

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

MEDPMedpace2026-06-26 15:30 EST

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

MEDPMedpace2026-06-26 15:30 EST

Medpace Holdings, Inc. Reports First Quarter 2025 Results

MEDPMedpace2026-06-26 15:30 EST

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

MEDPMedpace2026-06-26 15:30 EST

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States